TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS
The present invention refers to lixisenatide for use in pediatrics.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
24.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention refers to lixisenatide for use in pediatrics. |
---|---|
Bibliography: | Application Number: US202017028400 |